Employer interest in fertility and menopause programs, for example, skyrocketed in recent years, which may continue in the current political environment, experts say.
The federal agency recently called out the nation's leading pharmacy benefit managers for inflating prices, driving up pharmacy costs for both employers and employees.
The new president and Republican-controlled Congress likely will take significant actions affecting employer-sponsored healthcare. Employers should consider these actions when designing employee health strategy.
Paul Fronstin of the Employee Benefit Research Institute expects 2025 will bring continued challenges with rising healthcare and pharmacy costs, along with newer concerns with data integration and AI use.
On a recent WTW webinar, benefits experts explored how federal healthcare strategies impacting insurers and employers could change with the incoming Trump administration.
The rising cost of specialty drugs presents a significant challenge for employers, but it is possible to manage costs while optimizing employee health, this expert writes.
Pharmacy closures reduce access to healthcare services and create a public healthcare concern for insured employees. Solutions like personalized medication management are imperative to help reduce this crisis.
